Skip to main content

Psychological and Psychiatric Treatment of Chronic Head and Face Pain

  • Chapter
  • First Online:
  • 1101 Accesses

Abstract

Chronic head and facial pain is a multifaceted experience for patients, as it can pervasively affect the ability to function and ultimately hinder quality of life. Multidisciplinary approaches, including psychological and psychiatric interventions, for headache and facial pain are often necessary for successful treatment. Mood and anxiety symptoms, as well as deleterious health behaviors, can derail appropriate self-management, which then negatively affects medical management. This chapter will review cognitive-behavioral interventions, relaxation/biofeedback training, operant learning theory, the role of family support, and psychotropic medication options that can enhance health coping and effective head and facial pain management.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hamelsky SW, Lipton RB. Psychiatric comorbidities of migraine. Headache. 2006;46:1327–33. https://doi.org/10.1111/j.1526-4610.2006.00576.x.

    Article  PubMed  Google Scholar 

  2. Harris P, Loveman E, Clegg A, et al. Systematic review of cognitive behavioral therapy for the management of headaches and migraines in adults. Br J Pain. 2015;9(4):213–24. https://doi.org/10.1177/2049463715578291.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol. 2014;69(2):153–66. https://doi.org/10.1037/a0035747.

    Article  PubMed  Google Scholar 

  4. Moreira FP, Cardoso TA, Mondin TC, et al. The effect of proinflammatory cytokines in cognitive behavioral therapy. J Neuroimmunol. 2015;285:143–6.

    Article  CAS  PubMed  Google Scholar 

  5. Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother. 2009;9(5):745–58. https://doi.org/10.1586/ERN.09.34.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Borkum JM. Maladaptive cognitions and chronic pain: epidemiology, neurobiology, and treatment. J Ration Emot Cogn Behav Ther. 2010;28:4–24. https://doi.org/10.1007/s10942-010-0109-x.

    Article  Google Scholar 

  7. Singh NN, Sahota P. Sleep-related headache and its management. Curr Treat Options Neurol. 2013;15:704–22. https://doi.org/10.1007/s11940-013-0258-1.

    Article  PubMed  Google Scholar 

  8. Mitchell MD, Gehrman P, Umschied CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40–51. http://www.biomedcentral.com/1471-2296/13/40

    Article  PubMed  PubMed Central  Google Scholar 

  9. Schramm SH, Moebus S, Lehmann N, et al. The association between stress and headache: a longitudinal population-based study. Cephalalgia. 2015;35(10):853–63. https://doi.org/10.1177/0333102414563087.

    Article  PubMed  Google Scholar 

  10. Lipton RB, Buse DC, Hall CB, et al. Reduction in perceived stress as a migraine trigger: testing the “let-down headache” hypothesis. Neurology. 2014;82:1395–401.

    Article  PubMed  PubMed Central  Google Scholar 

  11. McGrady AV, Andrasik F, Davies T, et al. Psychophysiologic therapy for chronic headache in primary care. J Clin Psychiatry. 1999;1(4):96–102.

    Google Scholar 

  12. Rausa M, Palomba D, Cevoli S. Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. J Headache Pain. 2016;17:87–95. https://doi.org/10.1186/s10194-016-0679-9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Fordyce WE. Behavioral methods for chronic pain and illness. St Louis: C.V. Mosby; 1976.

    Google Scholar 

  14. Gatzounis R, Schrooten MGS, Crombez G, et al. Operant learning theory in pain and chronic pain rehabilitation. Curr Pain Headache Rep. 2012;16:117–26. https://doi.org/10.1007/s11916-012-0247-1.

    Article  PubMed  Google Scholar 

  15. Block AR, Kremer EF, Gaylor M. Behavioral treatment of chronic pain: the spouse as a discriminative cue for pain behavior. Pain. 1980;9:243–52.

    Article  CAS  PubMed  Google Scholar 

  16. Kerns RD, Haythornwaithe J, Southwick S, et al. The role of marital interaction in chronic pain and depressive symptom severity. J Psychosom Res. 1990;34(4):401–8.

    Article  CAS  PubMed  Google Scholar 

  17. Merikangas KR, Merikangas JR. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression. Biol Psychiatry. 1995;38(9):603–10.

    Article  CAS  PubMed  Google Scholar 

  18. Kuritzky A, Zoldan Y, Melamed E. MAO B inhibitor, is not effective in the prophylaxis of migraine without aura: an open study. Headache. 1992;32(8):416.

    Article  CAS  PubMed  Google Scholar 

  19. Doyle Strauss L, Weizenbaum E, Loder EW, et al. Amitriptyline dose and treatment outcomes in specialty headache practice: a retrospective cohort study. Headache. 2016;56(10):1626–34.

    Article  PubMed  Google Scholar 

  20. Linde M, Steiner TJ, Chisholm D. Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries. J Headache Pain. 2015;16:15.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Powers SW, Kashikar-Zuck SM, Allen JR. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310(24):2622–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kalita J, Bhoi SK, Misra UK. Amitriptyline vs divalproate in migraine prophylaxis: a randomized controlled trial. Acta Neurol Scand. 2013;128(1):65–72.

    Article  CAS  PubMed  Google Scholar 

  23. Pringsheim T, Davenport W, Mackie G, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2 Suppl 2):S1–59.

    PubMed  Google Scholar 

  24. Krymchantowski AV, da Cunha Jevoux C, Bigal ME. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders. J Headache Pain. 2012;13(1):53–9.

    Article  CAS  PubMed  Google Scholar 

  25. Domingues RB, Silva AL, Domingues SA, et al. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. Arq Neuropsiquiatr. 2009;67(4):973–7.

    Article  PubMed  Google Scholar 

  26. Lampl C, Huber G, Adl J, Luthringshausen G, et al. Two different doses of amitriptyline ER in the prophylaxis of migraine: long-term results and predictive factors. Eur J Neurol. 2009;16(8):943–8.

    Article  CAS  PubMed  Google Scholar 

  27. Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev. 2005;20(3):CD002919.

    Google Scholar 

  28. Tarlaci S. Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders. Clin Neuropharmacol. 2009;32(5):254–8.

    Article  CAS  PubMed  Google Scholar 

  29. Adly C, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache. 1992;32(2):101–4.

    Article  CAS  PubMed  Google Scholar 

  30. Saper JR, Silberstein SD, Lake AE, et al. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache. 1994;34(9):497–502.

    Article  CAS  PubMed  Google Scholar 

  31. Bulut S, Berilgen MS, Baran A, et al. Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg. 2004;107(1):44–8.

    Article  PubMed  Google Scholar 

  32. Young WB, Bradley KC, Anjum MW, et al. Duloxetine prophylaxis for episodic migraine in persons without depression: a prospective study. Headache. 2013;53(9):1430–7.

    PubMed  Google Scholar 

  33. Volpe FM. An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache. J Clin Psychiatry. 2008;69(9):1449–54.

    Article  CAS  PubMed  Google Scholar 

  34. Autret A, Valade D, Debiais S. Placebo and other psychological interactions in headache treatment. J Headache Pain. 2012;13:191–8. https://doi.org/10.1007/s10194-012-0422-0.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Taylor E. Rush .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rush, T.E., Goforth, H.W. (2018). Psychological and Psychiatric Treatment of Chronic Head and Face Pain. In: Suen, J., Petersen, E. (eds) Diagnosis and Management of Head and Face Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-90999-8_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90999-8_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90998-1

  • Online ISBN: 978-3-319-90999-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics